Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124315102 | 12431510 | 2 | F | 20160510 | 20160803 | 20160603 | 20160815 | EXP | US-TEVA-663074USA | TEVA | 61.75 | YR | F | Y | 0.00000 | 20160815 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124315102 | 12431510 | 1 | PS | CLOZAPINE. | CLOZAPINE | 1 | Unknown | Y | 74949 | ||||||||||
| 124315102 | 12431510 | 2 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 0 | |||||||||||
| 124315102 | 12431510 | 3 | C | LORAZEPAM. | LORAZEPAM | 1 | Unknown | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124315102 | 12431510 | OT |
| 124315102 | 12431510 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124315102 | 12431510 | Agranulocytosis | |
| 124315102 | 12431510 | Granulocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124315102 | 12431510 | 1 | 20160401 | 2016 | 0 |